[go: up one dir, main page]

BRPI0409277A - Method and composition for in vitro remodeling of a peptide molecule - Google Patents

Method and composition for in vitro remodeling of a peptide molecule

Info

Publication number
BRPI0409277A
BRPI0409277A BRPI0409277-5A BRPI0409277A BRPI0409277A BR PI0409277 A BRPI0409277 A BR PI0409277A BR PI0409277 A BRPI0409277 A BR PI0409277A BR PI0409277 A BRPI0409277 A BR PI0409277A
Authority
BR
Brazil
Prior art keywords
composition
peptide molecule
remodeling
peptide
vitro remodeling
Prior art date
Application number
BRPI0409277-5A
Other languages
Portuguese (pt)
Inventor
Shawn De Frees
David Zopf
Robert Bayer
Caryn Bowe
David Hakes
Xi Chen
Original Assignee
Neose Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/411,049 external-priority patent/US7297511B2/en
Priority claimed from US10/410,997 external-priority patent/US7157277B2/en
Priority claimed from US10/411,026 external-priority patent/US7795210B2/en
Priority claimed from US10/411,012 external-priority patent/US7265084B2/en
Priority claimed from US10/410,897 external-priority patent/US7179617B2/en
Priority claimed from US10/410,913 external-priority patent/US7265085B2/en
Priority claimed from US10/410,962 external-priority patent/US7173003B2/en
Priority claimed from US10/411,037 external-priority patent/US7125843B2/en
Priority claimed from US10/410,930 external-priority patent/US7226903B2/en
Priority claimed from US10/411,043 external-priority patent/US7439043B2/en
Application filed by Neose Technologies Inc filed Critical Neose Technologies Inc
Priority claimed from PCT/US2004/011494 external-priority patent/WO2004099231A2/en
Publication of BRPI0409277A publication Critical patent/BRPI0409277A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"MéTODO E COMPOSIçãO PARA A REMODELAGEM, IN VITRO, DE UMA MOLéCULA DE PEPTìDEO" A invenção inclui métodos e composições para remodelagem de uma molécula de peptídeo, incluindo a adição ou deleção de um ou mais grupos glicosil a um peptídeo e/ou a adição de um grupo de modificação a um peptídeo."METHOD AND COMPOSITION FOR IN VITRO REMODELING OF A PEPTIDE MOLECULE" The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide and / or addition from a modifying group to a peptide.

BRPI0409277-5A 2003-04-09 2004-04-09 Method and composition for in vitro remodeling of a peptide molecule BRPI0409277A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US10/410,997 US7157277B2 (en) 2001-11-28 2003-04-09 Factor VIII remodeling and glycoconjugation of Factor VIII
US10/411,026 US7795210B2 (en) 2001-10-10 2003-04-09 Protein remodeling methods and proteins/peptides produced by the methods
US10/411,012 US7265084B2 (en) 2001-10-10 2003-04-09 Glycopegylation methods and proteins/peptides produced by the methods
US10/410,897 US7179617B2 (en) 2001-10-10 2003-04-09 Factor IX: remolding and glycoconjugation of Factor IX
US10/411,049 US7297511B2 (en) 2001-10-10 2003-04-09 Interferon alpha: remodeling and glycoconjugation of interferon alpha
US10/410,913 US7265085B2 (en) 2001-10-10 2003-04-09 Glycoconjugation methods and proteins/peptides produced by the methods
US10/410,962 US7173003B2 (en) 2001-10-10 2003-04-09 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US10/411,037 US7125843B2 (en) 2001-10-19 2003-04-09 Glycoconjugates including more than one peptide
US10/410,930 US7226903B2 (en) 2001-10-10 2003-04-09 Interferon beta: remodeling and glycoconjugation of interferon beta
US10/411,043 US7439043B2 (en) 2001-10-10 2003-04-09 Galactosyl nucleotide sugars
PCT/US2004/011494 WO2004099231A2 (en) 2003-04-09 2004-04-09 Glycopegylation methods and proteins/peptides produced by the methods

Publications (1)

Publication Number Publication Date
BRPI0409277A true BRPI0409277A (en) 2006-03-21

Family

ID=36096013

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409277-5A BRPI0409277A (en) 2003-04-09 2004-04-09 Method and composition for in vitro remodeling of a peptide molecule

Country Status (1)

Country Link
BR (1) BRPI0409277A (en)

Similar Documents

Publication Publication Date Title
BR0213207A (en) peptide remodeling and glycoconjugation
MXPA05003730A (en) Erythropoietin: remodeling and glycoconjugation of erythropoietin.
EP2338333A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
BRPI0410630A (en) nk1 antagonist
SE0301010D0 (en) Novel compounds
SE0101675D0 (en) Novel composition
SE0301009D0 (en) Novel compounds
BRPI0513029A (en) method for producing a carbamylated erythropoietin protein, carbamylated erythropoietin protein, compound, pharmaceutical composition, methods of treating a chronic, sub-chronic and acute disease or condition and treating a disease of the central nervous system or peripheral nervous system, and , use of a compound
BR0307833A (en) Controlled synthesis of ziprasidone and its compositions
DK2207786T3 (en) 2'-Fluoro-2'-deoxytetrahydrouridines as cytidine deaminase inhibitors
BR0315178A (en) Erythropoietin: remodeling and glycoconjugation of erythropoietin
BRPI0408817A (en) compound, process for preparing same, pharmaceutical composition, and use of a compound
BRPI0601896A (en) compositions containing microgels and thickening agents
CY1109465T1 (en) NEW PHARMACEUTICAL MEDICINES FORMONTAFINILIS
EP1423137A4 (en) STEREO-ISOMERS OF LIPOPEPTIDE, METHODS OF PREPARATION AND USEFUL INTERMEDIATES
DE10193689D2 (en) Retardpartikeldispersion
BRPI0514411A (en) formulation, and method of producing a formulation
BR0315864A (en) Compositions and processes for the modification of toxic effects of proteinaceous compounds
CL2008003231A1 (en) Substituted 1,3-dihydro-5-isobenzofurancarbonitrile derivative compounds, selective serotonin reuptake inhibitors; pharmaceutical composition; preparation procedure; Useful in the treatment and / or prevention of premature ejaculation.
EA200601279A1 (en) PIPERIDINILKARBONILPYRROLIDINES AND THEIR APPLICATION AS AGANISTS OF MELANOCORTIN
BRPI0609765A8 (en) isoalkane mixture, method for the preparation thereof, cosmetic or pharmaceutical composition, and use of an isoalkane mixture
BR0308690A (en) Polysobutenamines, process for preparation and use thereof, additive concentrate, and fuel composition
PT1282418E (en) USE OF PYRAZOLE DERIVATIVES FOR THE TREATMENT OF INFERTILITY
MEP34308A (en) Oral formulations of cladribine
BR0303912A (en) Makeup for conditioning, makeup for durable conditioning, method for conditioning, method for lasting conditioning, method for care or treatment and kit for care, treatment, conditioning or lasting conditioning

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BIOGENERIX AG (DE)

Free format text: TRANSFERIDO DE: NEOSE TECHNOLOGIES, INC.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: BIOGENERIX AG (DE)

B25D Requested change of name of applicant approved

Owner name: BIOGENERIX GMBH (DE)

B25A Requested transfer of rights approved

Owner name: RATIOPHARM GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL